AGP Executive Report
Last update: 4 hours agoFederal Hemp Rules: A THC cap due Dec. 11 could sharply limit sales of hemp-derived products, including full-spectrum CBD. Rhode Island regulators say businesses may keep affected stock in quarantine, but cannot sell or distribute it unless rules change. Product Safety: Oklahoma recalled two medical marijuana batches after they failed yeast and mold testing; patients are urged to check batch numbers and contact their dispensary. The recall comes as Colorado’s auditor flags gaps in marijuana product testing. Rescheduling Watch: The DEA’s deadline on marijuana rescheduling is drawing attention, but the process remains stalled, leaving cannabis businesses and investors uncertain about what comes next.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.